Literature DB >> 26319442

Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension.

Yoshiharu Sada1, Yoshihiro Dohi2, Sayuri Uga1, Akifumi Higashi1, Hiroki Kinoshita1, Yasuki Kihara1.   

Abstract

Regulatory T cells (Tregs) have been reported to play a pivotal role in the vascular remodeling of pulmonary arterial hypertension (PAH). Recent studies have revealed that Tregs are heterogeneous and can be characterized by three phenotypically and functionally different subsets. In this study, we investigated the roles of Treg subsets in the pathogenesis of PAH in eight patients with PAH and 14 healthy controls. Tregs and their subsets in peripheral blood samples were analyzed by flow cytometry. Treg subsets were defined as CD4(+)CD45RA(+)FoxP3(low) resting Tregs (rTregs), CD4(+)CD45RA(-)FoxP3(high) activated Tregs (aTregs), and CD4(+)CD45RA(-)FoxP3(low) non-suppressive Tregs (non-Tregs). The proportion of Tregs among CD4(+) T cells was significantly higher in PAH patients than in controls (6.54 ± 1.10 vs. 3.81 ± 0.28 %, p < 0.05). Of the three subsets, the proportion of non-Tregs was significantly elevated in PAH patients compared with controls (4.06 ± 0.40 vs. 2.79 ± 0.14 %, p < 0.01), whereas those of rTregs and aTregs were not different between the two groups. Moreover, the expression levels of cytotoxic T lymphocyte antigen 4, a functional cell surface molecule, in aTregs (p < 0.05) and non-Tregs (p < 0.05) were significantly higher in PAH patients compared with controls. These results suggested the non-Treg subset was expanded and functionally activated in peripheral lymphocytes obtained from IPAH patients. We hypothesize that immunoreactions involving the specific activation of the non-Treg subset might play a role in the vascular remodeling of PAH.

Entities:  

Keywords:  Immune system; Inflammation; Pulmonary arterial hypertension; Regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 26319442     DOI: 10.1007/s00380-015-0727-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  30 in total

1.  Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.

Authors:  Rasa Tamosiuniene; Wen Tian; Gundeep Dhillon; Lijuan Wang; Yon K Sung; Lajos Gera; Andrew J Patterson; Rani Agrawal; Marlene Rabinovitch; Kelly Ambler; Carlin S Long; Norbert F Voelkel; Mark R Nicolls
Journal:  Circ Res       Date:  2011-08-25       Impact factor: 17.367

Review 2.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

3.  Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Authors:  Carl Atkinson; Susan Stewart; Paul D Upton; Rajiv Machado; Jennifer R Thomson; Richard C Trembath; Nicholas W Morrell
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

4.  Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

Authors:  Barbara Girerd; David Montani; Florence Coulet; Benjamin Sztrymf; Azzeddine Yaici; Xavier Jaïs; David Tregouet; Abilio Reis; Valérie Drouin-Garraud; Alain Fraisse; Olivier Sitbon; Dermot S O'Callaghan; Gérald Simonneau; Florent Soubrier; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

5.  Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension.

Authors:  Olivier Sanchez; Elisabeth Marcos; Frédéric Perros; Elie Fadel; Ly Tu; Marc Humbert; Philippe Dartevelle; Gérald Simonneau; Serge Adnot; Saadia Eddahibi
Journal:  Am J Respir Crit Care Med       Date:  2007-09-06       Impact factor: 21.405

6.  Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension.

Authors:  Silvia Ulrich; Mark R Nicolls; Laima Taraseviciene; Rudolf Speich; Norbert Voelkel
Journal:  Respiration       Date:  2007-11-20       Impact factor: 3.580

7.  Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children.

Authors:  S Hall; P Brogan; S G Haworth; N Klein
Journal:  Thorax       Date:  2009-06-11       Impact factor: 9.139

8.  BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.

Authors:  Rachel J Davies; Alan M Holmes; John Deighton; Lu Long; Xudong Yang; Lucy Barker; Christoph Walker; David C Budd; Paul D Upton; Nicholas W Morrell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-06       Impact factor: 5.464

9.  Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension.

Authors:  Alice Huertas; Ly Tu; Natalia Gambaryan; Barbara Girerd; Frédéric Perros; David Montani; Dominique Fabre; Elie Fadel; Saadia Eddahibi; Sylvia Cohen-Kaminsky; Christophe Guignabert; Marc Humbert
Journal:  Eur Respir J       Date:  2012-02-23       Impact factor: 16.671

10.  Autoimmunity and pulmonary hypertension in patients with Graves' disease.

Authors:  Tetsuro Sugiura; Shigeo Yamanaka; Hiroaki Takeuchi; Norihito Morimoto; Mikio Kamioka; Yoshihisa Matsumura
Journal:  Heart Vessels       Date:  2014-05-18       Impact factor: 2.037

View more
  8 in total

1.  Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.

Authors:  Levi D Maston; David T Jones; Wieslawa Giermakowska; Tamara A Howard; Judy L Cannon; Wei Wang; Yongyi Wei; Weimin Xuan; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-17       Impact factor: 5.464

Review 2.  The Role of Regulatory T Cells in Pulmonary Arterial Hypertension.

Authors:  Wen Tian; Shirley Y Jiang; Xinguo Jiang; Rasa Tamosiuniene; Dongeon Kim; Torrey Guan; Siham Arsalane; Shravani Pasupneti; Norbert F Voelkel; Qizhi Tang; Mark R Nicolls
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 8.786

Review 3.  A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension.

Authors:  A Josien Smits; Liza Botros; Marijke A E Mol; Kirsten A Ziesemer; Martin R Wilkins; Anton Vonk Noordegraaf; Harm Jan Bogaard; Jurjan Aman
Journal:  ERJ Open Res       Date:  2022-05-30

4.  Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.

Authors:  Rasa Tamosiuniene; Olga Manouvakhova; Paul Mesange; Toshie Saito; Jin Qian; Mrinmoy Sanyal; Yu-Chun Lin; Linh P Nguyen; Amir Luria; Allen B Tu; Joshua M Sante; Marlene Rabinovitch; Desmond J Fitzgerald; Brian B Graham; Aida Habtezion; Norbert F Voelkel; Laure Aurelian; Mark R Nicolls
Journal:  Circ Res       Date:  2018-03-15       Impact factor: 17.367

5.  Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection.

Authors:  Finja Schweitzer; Rebecca Tarantelli; Emily Rayens; Heather M Kling; Joshua T Mattila; Karen A Norris
Journal:  AIDS Res Hum Retroviruses       Date:  2018-10-30       Impact factor: 2.205

6.  Carbenoxolone decreases monocrotaline‑induced pulmonary inflammation and pulmonary arteriolar remodeling in rats by decreasing the expression of connexins in T lymphocytes.

Authors:  Liang Ζ Zhang; Zhi-Ru Fan; Lu Wang; Lu-Qian Liu; Xin-Zhi Li; Li Li; Jun-Qiang Si; Ke-Tao Ma
Journal:  Int J Mol Med       Date:  2019-11-13       Impact factor: 4.101

7.  Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension.

Authors:  Tove Lekva; Lars Gullestad; Kaspar Broch; Pål Aukrust; Arne K Andreassen; Thor Ueland
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

8.  Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension.

Authors:  Baptiste Gouyou; Katja Grün; Anne Kerschenmeyer; Alessandra Villa; Mattia Matasci; Andrea Schrepper; Alexander Pfeil; Laura Bäz; Christian Jung; P Christian Schulze; Dario Neri; Marcus Franz
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.